Krsnaa Diagnostics Future Growth
Future criteria checks 5/6
Krsnaa Diagnostics is forecast to grow earnings and revenue by 35.5% and 24.6% per annum respectively. EPS is expected to grow by 35.8% per annum. Return on equity is forecast to be 14.1% in 3 years.
Key information
35.5%
Earnings growth rate
35.8%
EPS growth rate
| Healthcare earnings growth | 27.6% |
| Revenue growth rate | 24.6% |
| Future return on equity | 14.1% |
| Analyst coverage | Low |
| Last updated | 14 Nov 2024 |
Recent future growth updates
Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 10
Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 16Recent updates
After Leaping 30% Krsnaa Diagnostics Limited (NSE:KRSNAA) Shares Are Not Flying Under The Radar
Nov 26Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Sep 06Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50
Aug 23Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 10Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Aug 09Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors
Jul 05Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return
Jun 16We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings
May 26Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?
Mar 14Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 16Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 31Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 17Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)
Jun 03Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 17Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)
Feb 16Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think
Nov 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 12,320 | 1,682 | 1,071 | 2,813 | 2 |
| 3/31/2026 | 10,227 | 1,184 | 336 | 1,864 | 3 |
| 3/31/2025 | 7,524 | 825 | -168 | 2,257 | 2 |
| 9/30/2024 | 6,812 | 692 | -1,147 | 439 | N/A |
| 6/30/2024 | 6,503 | 601 | N/A | N/A | N/A |
| 3/31/2024 | 6,196 | 568 | -1,695 | 243 | N/A |
| 12/31/2023 | 5,866 | 570 | N/A | N/A | N/A |
| 9/30/2023 | 5,464 | 577 | -677 | 842 | N/A |
| 6/30/2023 | 5,138 | 625 | N/A | N/A | N/A |
| 3/31/2023 | 4,871 | 621 | -651 | 763 | N/A |
| 12/31/2022 | 4,621 | 611 | N/A | N/A | N/A |
| 9/30/2022 | 4,505 | 638 | -1,125 | 477 | N/A |
| 6/30/2022 | 4,358 | 610 | N/A | N/A | N/A |
| 3/31/2022 | 4,555 | 684 | -38 | 1,284 | N/A |
| 12/31/2021 | 4,431 | 395 | N/A | N/A | N/A |
| 3/31/2021 | 3,965 | 1,849 | 357 | 1,026 | N/A |
| 12/31/2020 | 3,694 | 1,307 | 256 | 963 | N/A |
| 3/31/2020 | 2,584 | -1,120 | -389 | 378 | N/A |
| 3/31/2019 | 2,092 | -621 | -415 | 583 | N/A |
| 3/31/2018 | 1,076 | -602 | N/A | 391 | N/A |
| 3/31/2017 | 569 | -39 | N/A | 622 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KRSNAA's forecast earnings growth (35.5% per year) is above the savings rate (6.7%).
Earnings vs Market: KRSNAA's earnings (35.5% per year) are forecast to grow faster than the Indian market (18.1% per year).
High Growth Earnings: KRSNAA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: KRSNAA's revenue (24.6% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: KRSNAA's revenue (24.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KRSNAA's Return on Equity is forecast to be low in 3 years time (14.1%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 21:34 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Krsnaa Diagnostics Limited is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bharat Celly | Equirus Securities Private Limited |
| Cyndrella Carvalho | JM Financial Institutional Securities Limited |
| Jainil Shah | JM Financial Institutional Securities Limited |